This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Aloyz R, Panasci L . Reply to the letter of Chow KU, Nowak D, Hofmann W, Schneider B, Hofmann WK. Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4. Leukemia 2005, April 7 [E-pub ahead of print].
Chow KU, Nowak D, Hofmann W, Schneider B, Hofmann WK . Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4. Leukemia 2005, April 7 [E-pub ahead of print].
Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L . Imatinib sensitizes CLL lymphocytes to chlorambucil. Leukemia 2004; 18: 409–414.
Boehrer S, Chow KU, Beske F, Kukoc-Zivojnov N, Puccetti E, Ruthardt M et al. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. Cancer Res 2002; 62: 1768–1775.
Gurumurthy S, Rangnekar VM . Par-4 inducible apoptosis in prostate cancer cells. J Cell Biochem 2004; 91: 504–512.
Chow KU, Nowak D, Boehrer S, Ruthardt M, Knau A, Hoelzer D et al. Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation. Biochem Pharmacol 2003; 66: 711–724.
Boehrer S, Nowak D, Hochmuth S, Kim SZ, Trepohl B, Afkir A et al. Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways. Cell Signal 2005; 17: 581–595.
Author information
Authors and Affiliations
Additional information
No further reply from Dr Aloyz.
Rights and permissions
About this article
Cite this article
Chow, K., Nowak, D., Hofmann, W. et al. Reply to Aloyz et al. Leukemia 19, 1106–1107 (2005). https://doi.org/10.1038/sj.leu.2403742
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403742